VRTX (VRTX) Stock Price & Analysis
VRTX (VRTX) fell 2.12% to USD 546.12 as of September 8, 2026 at 06:57 UTC, according to Nexqual real-time market data.
VRTX last closed at USD 546.12; the session ranged USD 544.48–556.41 on volume of 803,524 shares. Market capitalization is —, with a 52-week range of USD 374.17–560.25 (NMS). Source: Nexqual, September 8, 2026 at 06:57 UTC.
Key Statistics (as of September 8, 2026 at 06:57 UTC)
| Price | USD 546.12 |
|---|---|
| Change | ▼ 2.12% (down) |
| Previous Close | USD 546.12 |
| Open | USD 546.12 |
| Day Range | USD 544.48 – 556.41 |
| 52-Week Range | USD 374.17 – 560.25 |
| Volume | 803,524 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (VRTX)
Nexqual's technical model rates VRTX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:57 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 59.34 (neutral) |
| vs SMA50 | Above (USD 508.76) |
| MACD | 14.76 (positive) |
From VRTX's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | USD 827.72 | ▼ 2.85% |
| BIIB | Biogen Inc. | USD 220.83 | ▼ 0.83% |
| INCY | Incyte Corporation | USD 126.75 | ▼ 1.61% |
| ILMN | Illumina, Inc. | USD 218.22 | ▲ 2.33% |
| BMRN | BioMarin Pharmaceutical Inc. | USD 66.53 | ▼ 0.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:57 UTC. This page is informational and not investment advice.